Pharmaceuticals

WHYY

WHYY released FY2026 Q1 earnings on April 7 After-Market (BJT), actual revenue CNY 219.05 M, actual EPS CNY 0.06

WHYY to Release FY2026 Q1 Earnings on April 8 After-Market (BJT)

WHYY released FY2025 Annual Earnings on January 19 Pre-Market (BJT), with actual revenue of CNY 816.95 M and EPS of CNY 0.17

WHYY released FY2025 Q4 earnings on January 19 Pre-Market (BJT), actual revenue CNY 192.34 M, actual EPS CNY 0.0625

WHYY to Release FY2025 Annual Earnings on January 20, 2026 Pre-Market BJT

WHYY released FY2025 Q3 earnings on October 17 After-Market (BJT), actual revenue CNY 199.25 M, actual EPS CNY 0.0307

WHYY released FY2025 9 Months Earnings on October 17 After-Market BJT, actual revenue CNY 624.61 M, actual EPS CNY 0.1107

WHYY to Release FY2025 Q3 Earnings on October 18 After-Market (BJT)

Wohua Pharmaceutical Reports Significant Q2 Earnings Increase and Dividend Plan

WHYY released FY2025 Q2 earnings on July 21 Pre-Market (BJT), actual revenue CNY 207.52 M, actual EPS CNY 0.04

WHYY released FY2025 Semi-Annual Earnings on July 21 Pre-Market BJT, Actual Revenue: CNY 425.36 M, Actual EPS: CNY 0.08

WHYY to Release FY2025 Semi-Annual Earnings on July 22, 2025 (BJT)

Wohua Pharmaceutical's Net Profit for First Half of 2025 Projected to Increase by 233.89% to 378.27%

Wo Hua Medicine's ESG Rating Remains CCC

WHYY released FY2024 Q4 earnings on April 25 After-Market BJT, actual revenue CNY 187.11 M, actual EPS CNY 0.019

WHYY released FY2025 Q1 earnings on April 25 After-Market BJT, actual revenue CNY 217.84 M, actual EPS CNY 0.04

WHYY released FY2024 Annual Earnings on April 25 After-Market (BJT), Actual Revenue CNY 763.79 M, Actual EPS CNY 0.06

WHYY FY2025 Q1 Earnings Release Scheduled for April 26 After-Market BJT

WHYY FY2024 Annual Earnings Release Scheduled for April 26, 2025 After-Market BJT

Shandong Wohua Pharmaceutical to Release Q3 2024 Earnings on October 26, 2024

The global stigmasterol-rich plant sterols market is projected to reach USD 1,281.42 million by 2036, driven by rising cardiovascular health awareness and demand for functional foods. The market is transitioning towards standardized formulations and regulatory support, with significant growth in applications across food, nutraceuticals, and pharmaceuticals. Key growth regions include India, Germany, and China, with a forecast CAGR of 3.8% from 2026 to 2036. The market is bolstered by increasing consumer preference for plant-based wellness solutions and regulatory approvals for health claims.

MorningStar

Stigmasterol-Rich Plant Sterols Market to Reach USD 1,281.42 Million by 2036 as Cardiovascular Health Awareness and Functional Food Demand Expand Globally

002107

WHYY released its third-quarter report for 2025, with operating revenue for the first three quarters amounting to 625 million yuan, a year-on-year increase of 8.31%. The net profit attributable to the parent company was 63.995 million yuan, a year-on-year increase of 179.34%; the net profit after deducting non-recurring gains and losses was 61.2711 million yuan, a year-on-year increase of 187.87%. The basic earnings per share were 0.11 yuan

Zhitong

WHYY released its performance for the first three quarters, with a net profit attributable to the parent company of 63.995 million yuan, an increase of 179.34%

WHYY announced that director and board secretary Zhang Ge holds 10.0588 million shares of the company, accounting for 1.74% of the total share capital. He plans to reduce his holdings by no more than 2.5147 million shares, accounting for 0.44% of the total share capital, within three months after 15 trading days from the date of this announcement, through centralized bidding. The shares to be reduced come from his holdings prior to the company's initial public offering and from historical bonus shares, with the reduction price to be determined by the market price at that time

WHYY: Directors plan to reduce holdings by 0.44%

As of July 24, 2025, 11 companies have disclosed their semi-annual reports for 2025. Among them, Changchuan Technology, Haitong Development, Minshida, and 2 other companies have received increased positions from institutions, with Changchuan Technology's increase exceeding 4 percentage points. Only WHYY has seen an increase from qualified foreign institutional investors, with the QFII shareholding ratio reaching 1.09%

11 companies disclosed their semi-annual reports for 2025, only WHYY saw an increase in holdings from QFII on a quarter-on-quarter basis

300604

300708

002997

The first batch of semi-annual reports from the Shenzhen Stock Exchange has been released, with WHYY, FOCUS LIGHTINGS, RAYHOO MOTOR DIES, CCTech, and *ST Lingda reporting their performance. Except for *ST Lingda, the other four companies achieved positive growth in both revenue and net profit. Among them, WHYY had the highest year-on-year increase in net profit, reaching 303.16%, with a revenue of 425 million yuan and a net profit of 44.6764 million yuan, and will distribute a cash dividend of 1.20 yuan for every 10 shares

CCTech

FOCUS LIGHTINGS

RAYHOO MOTOR DIES

The first batch of semi-annual reports from the Shenzhen Stock Exchange has been released, with four companies showing "double growth" in performance

WHYY released its 2025 semi-annual report, with revenue of 425 million yuan, a year-on-year increase of 7.64%; net profit attributable to shareholders of 44.68 million yuan, a year-on-year increase of 303.16%; net profit excluding non-recurring items of 42.74 million yuan, a year-on-year increase of 334.8%; basic earnings per share of 0.08 yuan. The company plans to distribute a cash dividend of 1.20 yuan for every 10 shares to all shareholders. Revenue from cardiovascular drugs was 294.2304 million yuan, a year-on-year increase of 11.53%

WHYY released its semi-annual performance report, with a net profit attributable to the parent company of 44.68 million yuan, a year-on-year increase of 303.16%

WHYY expects a net profit of RMB 37 million to RMB 53 million in the first half of 2025, a year-on-year increase of 233.89% to 378.27%. The net profit after deducting non-recurring gains and losses is expected to be RMB 34.2 million to RMB 48.5 million, a year-on-year increase of 247.96% to 393.45%. The company has achieved revenue growth by adapting to market changes, adjusting its marketing model and market layout, while effectively compressing costs and expenses by reducing the procurement costs of key raw materials and implementing cost reduction and efficiency enhancement measures, thereby improving operating profit

WHYY issued a profit warning, expecting a net profit of 37 million to 53 million yuan in the first half of the year, a year-on-year increase of 233.89% to 378.27%

WHYY(002107.SZ)